Which TNF inhibitor is dosed as 50 mg subcutaneously every month?

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $9.99Unlock all

Enhance your dermatological knowledge with the Dermatology Week 1 Exam. Engage with multiple choice questions that provide insights and detailed explanations to gear you up for testing success. Prepare effectively for your exam!

Multiple Choice

Which TNF inhibitor is dosed as 50 mg subcutaneously every month?

Explanation:
Dosing frequency differentiates TNF inhibitors. Golimumab (Simponi) is given as 50 mg subcutaneously once every 4 weeks. In contrast, adalimumab (Humira) is typically 40 mg every other week (with some regimens adjusted to weekly), etanercept (Enbrel) is usually 50 mg weekly (or 25 mg twice weekly), and infliximab (Remicade) is administered by IV infusion every 6–8 weeks after induction. Because the question specifies 50 mg subcutaneously every month, this matches Simponi best.

Dosing frequency differentiates TNF inhibitors. Golimumab (Simponi) is given as 50 mg subcutaneously once every 4 weeks. In contrast, adalimumab (Humira) is typically 40 mg every other week (with some regimens adjusted to weekly), etanercept (Enbrel) is usually 50 mg weekly (or 25 mg twice weekly), and infliximab (Remicade) is administered by IV infusion every 6–8 weeks after induction. Because the question specifies 50 mg subcutaneously every month, this matches Simponi best.

More Multiple Choice Questions
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy